Eric Joseph
Stock Analyst at Citi
(4.45)
# 1,156
Out of 4,988 analysts
340
Total ratings
51.2%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | n/a | $68.79 | - | 2 | Sep 16, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | n/a | $64.06 | - | 6 | Sep 14, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $100 | $44.90 | +122.72% | 5 | Sep 4, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $340 | $244.32 | +39.16% | 5 | Aug 31, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $355 → $360 | $237.59 | +51.52% | 2 | Aug 14, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Hold | $93 → $94 | $66.58 | +41.18% | 5 | Aug 12, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $99 | $67.56 | +46.54% | 3 | Jul 16, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $67 → $108 | $65.26 | +65.49% | 31 | Jun 10, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | $46 → $49 | $57.16 | -14.28% | 18 | Nov 3, 2025 | |
| PLRX Pliant Therapeutics | Downgraded: Sell | n/a | $1.11 | - | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $25.26 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $117.67 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $3.27 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $10.41 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.19 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $4.17 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.54 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $11 | $18.19 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $10.88 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.69 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $12 | $12.26 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $4.26 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $70 | $192.76 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $5 | $12.11 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $25.41 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $1.71 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7 | $3.30 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $10 | $3.97 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $1.85 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $10.93 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $5.43 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $1.94 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $16.53 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $1.86 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $5.49 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $13 | $4.41 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $7 | $1.95 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.9385 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $6.50 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $18.49 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.0001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $26 | $43.20 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.70 | n/a | 1 | Feb 7, 2020 |
Arrowhead Pharmaceuticals
Sep 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $68.79
Upside: -
BioMarin Pharmaceutical
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $64.06
Upside: -
Ionis Pharmaceuticals
Sep 4, 2026
Reiterated: Buy
Price Target: $100
Current: $44.90
Upside: +122.72%
Alnylam Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $340
Current: $244.32
Upside: +39.16%
Ascendis Pharma
Aug 14, 2026
Reiterated: Buy
Price Target: $355 → $360
Current: $237.59
Upside: +51.52%
BridgeBio Pharma
Aug 12, 2026
Reiterated: Hold
Price Target: $93 → $94
Current: $66.58
Upside: +41.18%
Cytokinetics
Jul 16, 2026
Reiterated: Buy
Price Target: $99
Current: $67.56
Upside: +46.54%
PTC Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $67 → $108
Current: $65.26
Upside: +65.49%
TG Therapeutics
Nov 3, 2025
Reiterated: Buy
Price Target: $46 → $49
Current: $57.16
Upside: -14.28%
Pliant Therapeutics
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $1.11
Upside: -
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $25.26
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $117.67
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $3.27
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $10.41
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.19
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $22 → $18
Current: $4.17
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $38.54
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $21 → $11
Current: $18.19
Upside: n/a
May 7, 2025
Reiterated: Hold
Price Target: $14
Current: $10.88
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.69
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $15 → $12
Current: $12.26
Upside: n/a
Mar 4, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $4.26
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $71 → $70
Current: $192.76
Upside: n/a
Feb 10, 2025
Reiterated: Sell
Price Target: $9 → $5
Current: $12.11
Upside: n/a
Jan 29, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $25.41
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $1.71
Upside: n/a
Feb 23, 2024
Reiterated: Hold
Price Target: $6 → $7
Current: $3.30
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: $11 → $10
Current: $3.97
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $1.85
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $10.93
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $5.43
Upside: n/a
May 5, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $1.94
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $16.53
Upside: n/a
Nov 4, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $1.86
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $5.49
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $12 → $13
Current: $4.41
Upside: n/a
Mar 29, 2022
Reiterated: Buy
Price Target: $24 → $7
Current: $1.95
Upside: n/a
Mar 4, 2022
Reiterated: Sell
Price Target: n/a
Current: $0.9385
Upside: n/a
Nov 11, 2021
Reiterated: Hold
Price Target: $14 → $11
Current: $6.50
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $18.49
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 21, 2020
Reiterated: Hold
Price Target: $39 → $26
Current: $43.20
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $7.70
Upside: n/a